Torthaí cuardaigh - J Louwers
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease de réir Remi Mahmoud, H. Schultheiss, J Louwers, Michiel van der Kaaij, B van Hellemondt, Nofel Mahmmod, P van Boeckel, Bindia Jharap, Herma H. Fidder, Bas Oldenburg
Foilsithe / Cruthaithe 2022Artigo -
2
Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease de réir J Schultheiss, Remi Mahmoud, J Louwers, Michiel T. van der Kaaij, Boris P. van Hellemondt, Petra G. Van Boeckel, Nofel Mahmmod, Bindia Jharap, Herma H. Fidder, Bas Oldenburg
Foilsithe / Cruthaithe 2021Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Confidence interval
Discontinuation
Disease
Gastroenterology
Hazard ratio
Inflammatory bowel disease
Infliximab
Internal medicine
Medicine
Proportional hazards model
Retrospective cohort study
Adalimumab
Cohort
Concomitant
Crohn's disease
Incidence (geometry)
Interquartile range
Odds ratio
Optics
Physics
Rheumatoid arthritis
Surgery
Tacrolimus
Transplantation
Trough level
Tumor necrosis factor alpha
Ulcerative colitis